The complete or partial METCAM/MUC18 recombinant protein, oligopeptides derived from METCAM/MUC18, or small molecule mimetics of METCAM/MUC18 may also be administered into the ovarian carcinoma patients. The gene discussed is MCAM; the disease is ovarian carcinoma.